Loading company details...
Beta
Latest Form 4 (Sep 2, 2026): Ian Sheffield (Director): Grant/Award of 100,000 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Ian Sheffield | Grant/Award | 100,000 | n/a |
| Sep 1, 2026 | Marc Elia, Chief Executive Officer | Grant/Award | 10,700,000 | n/a |
| Aug 19, 2026 | Timothy Edward Lee, Chief Commercial Officer | Exercise/Conversion | 102,000 | n/a |
| Aug 19, 2026 | Julie Green, Chief Human Resources Officer | Exercise/Conversion | 102,000 | n/a |
| Aug 19, 2026 | William E. Duke, Chief Financial Officer | Exercise/Conversion | 102,000 | n/a |
| Aug 19, 2026 | Jill Andersen, Chief Legal Officer, Secretary | Exercise/Conversion | 170,000 | n/a |
| Aug 19, 2026 | Robert D. Allen III, Chief Scientific Officer | Exercise/Conversion | 102,000 | n/a |
| Aug 4, 2026 | Michael Mina, CMO and Chief Epidemiologist | Grant/Award | 1,125,000 | n/a |
| May 21, 2026 | Ajay Royan | Grant/Award | 50,000 | n/a |
| May 21, 2026 | Kevin F. Mclaughlin | Grant/Award | 50,000 | n/a |